Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine · Shinde A, Mohan A, Bulusu VM et al.

References

  1. AggarwalS. WaliaK. JM. GopalkrishnanR. OhriV. GangakhedkarR. (2019). Treatment Guidelines for Antimicrobial Use in Common Syndromes 2019 New Delhi, India i ICMR, New Delhi Treatment Guidelines for Antimicrobial Use in Common Syndromes. 2nd edition Available online at: https://www.researchgate.net/publication/336511625_Treatment_Guidelines_for_Antimicrobial_Use_in_Common_Syndromes_2019_New_Delhi_India_i_ICMR_New_Delhi_Treatment_Guidelines_for_Antimicrobial_Use_in_Common_Syndromes_2_nd_edition.
  2. AhmedS. K. HusseinS. QurbaniK. IbrahimR. H. FareeqA. MahmoodK. A. . (2024c). Antimicrobial resistance: Impacts, challenges, and future prospects. J. Medicine Surgery Public Health 2, 100081. doi: 10.1016/j.glmedi.2024.100081
  3. AhmedF. ShamimN. J. DasA. SharmaH. K. GrewalA. S. PanditaD. . (2024a). Combating Antimicrobial Resistance: A paradigm shift from general to precision medicine. Chem. Biol. Lett. 11, 662. doi: 10.62110/sciencein.cbl.2024.v11.662
  4. AhmedS. ShamsS. TrivediD. LimaC. McgalliardR. ParryC. M. . (2024b). Metabolic response of Klebsiella oxytoca to ciprofloxacin exposure: a metabolomics approach. Metabolomics 21, 8. doi: 10.1007/s11306-024-02206-y, PMID: 39676074 PMC11646952
  5. AllegraS. CardellinoC. S. FatigusoG. CusatoJ. De NicolòA. AvataneoV. . (2018a). Effect of ABCC2 and ABCG2 gene polymorphisms and CSF-to-serum albumin ratio on ceftriaxone plasma and cerebrospinal fluid concentrations. J. Clin. Pharmacol. 58, 1550–1556. doi: 10.1002/jcph.1266, PMID: 29873816
  6. AllegraS. Di PaoloA. CusatoJ. FatigusoG. ArrigoniE. DanesiR. . (2018b). A common mdr1 gene polymorphism is associated with changes in linezolid clearance. Ther. Drug Monit. 40, 602–609. doi: 10.1097/ftd.0000000000000536, PMID: 29979333
  7. AlsanM. KammiliN. LakshmiJ. XingA. KhanA. RaniM. . (2018). Poverty and community-acquired antimicrobial resistance with extended-spectrum β-lactamase-producing organisms, Hyderabad, India. Emerg. Infect. Dis. 24, 1490–1496. doi: 10.3201/eid2408.171030, PMID: 30014842 PMC6056104
  8. AndersenB. M. (2019). “ Prevention of postoperative wound infections,” in Prevention and Control of Infections in Hospitals: Practice and Theory ( Springer International Publishing, Cham). doi: 10.1007/978-3-319-99921-0_33
  9. AndrewsE. ArmstrongM. TugwoodJ. SwanD. GlavesP. PirmohamedM. . (2010). A role for the pregnane X receptor in flucloxacillin-induced liver injury. Hepatology 51, 1656–1664. doi: 10.1002/hep.23549, PMID: 20222094
  10. BaiettoL. D’avolioA. CusatoJ. PaceS. CalcagnoA. MottaI. . (2015). Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. J. Antimicrobial Chemotherapy 70, 307–308. doi: 10.1093/jac/dku368, PMID: 25239468
  11. BalachandraS. S. SawantP. S. HuilgolP. G. VithyaT. KumarG. PrasadR. (2021). Antimicrobial resistance (AMR) at the community level: An urban and rural case study from Karnataka. J. Family Med. Primary Care 10, 1404–1411. doi: 10.4103/jfmpc.jfmpc_888_20, PMID: 34041186 PMC8140222
  12. BankarN. J. UgemugeS. AmbadR. S. HawaleD. V. TimilsinaD. R. (2022). Implementation of antimicrobial stewardship in the healthcare setting. Cureus 14, e26664. doi: 10.7759/cureus.26664, PMID: 35949742 PMC9357433
  13. Barrasa-VillarJ. I. Aibar-RemónC. Prieto-AndrésP. Mareca-DoñateR. Moliner-LahozJ. (2017). Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin. Infect. Dis. 65, 644–652. doi: 10.1093/cid/cix411, PMID: 28472416
  14. BiswasM. BiswasS. GuptaB. MascellinoM. T. RakshitA. ChakrabortyB. (2022). Changing paradigms in antibiotic resistance in salmonella species with focus on fluoroquinolone resistance: A 5-year retrospective study of enteric fever in a tertiary care hospital in Kolkata, India. Antibiotics 11, 1308. doi: 10.3390/antibiotics11101308, PMID: 36289966 PMC9598680
  15. BiswasS. KhuntiaH. K. BalM. PatiS. DixitS. PattanaikS. S. S. . (2024). Prevalence and antimicrobial resistance patterns of diarrheagenic and uropathogenic Escherichia coli in Odisha, India. One Health Bull. 4, 85–92. doi: 10.4103/ohbl.ohbl_42_23
  16. BoseP. ChowdhuryG. HalderG. GhoshD. DebA. K. KitaharaK. . (2024). Prevalence and changing antimicrobial resistance profiles of Shigella spp. isolated from diarrheal patients in Kolkata during 2011–2019. PloS Negl. Trop. Dis. 18, e0011964. doi: 10.1371/journal.pntd.0011964, PMID: 38377151 PMC10906866
  17. ChenH.-K. HsiehY.-W. HsuH.-Y. LiuT.-Y. ZhangY.-T. LinC.-D. . (2024). Increased risk of hearing loss associated with MT-RNR1 gene mutations: a real-world investigation among Han Taiwanese Population. BMC Med. Genomics 17, 155. doi: 10.1186/s12920-024-01921-8, PMID: 38840095 PMC11155076
  18. ChengZ.-X. GongQ.-Y. WangZ. ChenZ.-G. YeJ.-Z. LiJ. . (2017). Edwardsiella tarda tunes tricarboxylic acid cycle to evade complement-mediated killing. Front. Immunol. 8. doi: 10.3389/fimmu.2017.01706, PMID: 29270172 PMC5725468
  19. CirulliE. T. NicolettiP. AbramsonK. AndradeR. J. BjornssonE. S. ChalasaniN. . (2019). A missense variant in PTPN22 is a risk factor for drug-induced liver injury. Gastroenterology 156, 1707–1716.e2. doi: 10.1053/j.gastro.2019.01.034, PMID: 30664875 PMC6511989
  20. Cornejo-JuárezP. Vilar-CompteD. Pérez-JiménezC. Ñamendys-SilvaS. A. Sandoval-HernándezS. Volkow-FernándezP. (2015). The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int. J. Infect. Dis. 31, 31–34. doi: 10.1016/j.ijid.2014.12.022, PMID: 25528484
  21. CrankC. O’DriscollT. (2015). Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infection Drug Resistance 8, 217–30. doi: 10.2147/IDR.S54125, PMID: 26244026 PMC4521680
  22. CusumanoJ. A. KlinkerK. P. HuttnerA. LutherM. K. RobertsJ. A. LaplanteK. L. (2020). Towards precision medicine: Therapeutic drug monitoring–guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity. Am. J. Health-System Pharm. 77, 1104–1112. doi: 10.1093/ajhp/zxaa128, PMID: 32537644
  23. DadgostarP. (2019). Antimicrobial resistance: implications and costs. Infection Drug Resistance 12, 3903–3910. doi: 10.2147/IDR.S234610, PMID: 31908502 PMC6929930
  24. DalyA. K. (2023). Relevance of pharmacogenomics to the safe use of antimicrobials. Antibiotics 12, 425. doi: 10.3390/antibiotics12030425, PMID: 36978292 PMC10044203
  25. DekaS. KalitaD. MahantaP. BaruahD. (2020). High prevalence of antibiotic-resistant gram-negative bacteria causing surgical site infection in a tertiary care hospital of northeast India. Cureus 12, e12208. doi: 10.7759/cureus.12208, PMID: 33489616 PMC7815295
  26. DortetL. BonninR. A. PennisiI. GauthierL. JoussetA. B. DabosL. . (2018). Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test. J. Antimicrobial Chemotherapy 73, 3359–3367. doi: 10.1093/jac/dky330, PMID: 30184212
  27. Dr. RanjeetS. Dr. Krishna GopalS. Dr. FarhaS. Dr. HarshaG. (2024). Prevalence and impact of nosocomial infections in the ICU of A tertiary care hospital in central India. Educ. Administration: Theory Pract. 30, 1574–1578. doi: 10.53555/kuey.v30i6.5540
  28. EstivillX. GoveaN. BarcelóA. PerellóE. BadenasC. RomeroE. . (1998). Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am. J. Hum. Genet. 62, 27–35. doi: 10.1086/301676, PMID: 9490575 PMC1376822
  29. FeldmanC. ShaddockE. (2019). Epidemiology of lower respiratory tract infections in adults. Expert Rev. Respir. Med. 13, 63–77. doi: 10.1080/17476348.2019.1555040, PMID: 30518278
  30. Figueiredo CostaS. (2008). Impact of antimicrobial resistance on the treatment and outcome of patients with sepsis. Shock 30, 23–29. doi: 10.1097/SHK.0b013e3181818990, PMID: 18704013
  31. Figueroa-EspinosaR. CostaA. CejasD. BarriosR. VayC. RadiceM. . (2019). MALDI-TOF MS based procedure to detect KPC-2 directly from positive blood culture bottles and colonies. J. Microbiological Methods 159, 120–127. doi: 10.1016/j.mimet.2019.02.020, PMID: 30849422
  32. FrankeR. M. LancasterC. S. PeerC. J. GibsonA. A. KosloskeA. M. OrwickS. J. . (2011). Effect of ABCC2 (MRP2) transport function on erythromycin metabolism. Clin. Pharmacol. Ther. 89, 693–701. doi: 10.1038/clpt.2011.25, PMID: 21451505 PMC4519823
  33. GandraS. SinghS. K. JinkaD. R. KanithiR. ChikkappaA. K. SharmaA. . (2017). Point prevalence surveys of antimicrobial use among hospitalized children in six hospitals in India in 2016. Antibiotics 6, 19. doi: 10.3390/antibiotics6030019, PMID: 28902135 PMC5617983
  34. GervasoniC. CattaneoD. FalvellaF. S. VitielloP. CheliS. MilazzoL. . (2013). Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics. Eur. J. Clin. Pharmacol. 69, 1611–1613. doi: 10.1007/s00228-013-1515-7, PMID: 23616064
  35. GuptaR. BhatiaR. (2023). “ Antimicrobial resistance in India: the road ahead,” in Handbook on Antimicrobial Resistance: Current Status, Trends in Detection and Mitigation Measures. Eds. MothadakaM. P. Nagarajrao RavishankarC. VaiyapuriM. BhatiaR. JenaJ. Rao BadireddyM. ( Springer Nature Singapore, Singapore). doi: 10.1007/978-981-16-9723-4_1-2
  36. HaD. R. HasteN. M. GlucksteinD. P. (2019). The role of antibiotic stewardship in promoting appropriate antibiotic use. Am. J. Lifestyle Med. 13, 376–383. doi: 10.1177/1559827617700824, PMID: 31285722 PMC6600622
  37. HahnA. FukudaT. HahnD. MizunoT. FrenckR. W. VinksA. A. (2016). Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropenia. Pharmacogenomics 17, 547–559. doi: 10.2217/pgs-2015-0008, PMID: 27045542 PMC5558518
  38. HassounA. LindenP. K. FriedmanB. (2017). Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment. Crit. Care 21, 211. doi: 10.1186/s13054-017-1801-3, PMID: 28807042 PMC5557425
  39. IskandarK. MolinierL. HallitS. SartelliM. CatenaF. CoccoliniF. . (2020). Drivers of antibiotic resistance transmission in low- and middle-income countries from a “One health” Perspective—A Review. Antibiotics 9, 372. doi: 10.3390/antibiotics9070372, PMID: 32630353 PMC7400606
  40. JainP. A. KulkarniR. D. DuttaS. GanavaliA. S. KalabhaviA. S. ShettyP. C. . (2020). Prevalence and antimicrobial profile of shigella isolates in a tertiary care hospital of north karnataka: A 12-year study. Indian J. Med. Microbiol. 38, 101–108. doi: 10.4103/ijmm.IJMM_20_107, PMID: 32719216
  41. JainN. LodhaR. KabraS. K. (2001). Upper respiratory tract infections. Indian J. Pediatr. 68, 1135–1138. doi: 10.1007/BF02722930, PMID: 11838568 PMC7091368
  42. JaniK. SrivastavaV. SharmaP. VirA. SharmaA. (2021). Easy access to antibiotics; spread of antimicrobial resistance and implementation of one health approach in India. J. Epidemiol. Global Health 11, 444–452. doi: 10.1007/s44197-021-00008-2, PMID: 34734384 PMC8477994
  43. JeanS.-S. HarnodD. HsuehP.-R. (2022). Global threat of carbapenem-resistant gram-negative bacteria. Front. Cell. Infection Microbiol. 12. doi: 10.3389/fcimb.2022.823684, PMID: 35372099 PMC8965008
  44. JesudasonT. (2024). WHO publishes updated list of bacterial priority pathogens. Lancet Microbe 5, 100940. doi: 10.1016/j.lanmic.2024.07.003, PMID: 39079540
  45. JevericaS. SókiJ. PremruM. M. NagyE. PapstL. (2019). High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS. Anaerobe 58, 30–34. doi: 10.1016/j.anaerobe.2019.01.011, PMID: 30716401
  46. KadamA. MamulwarM. BhambureG. BembalkarS. BapatS. ManeA. . (2024). Incremental cost of treating antimicrobial-resistant infections among hospitalised patients in India: a cohort study. BMJ Open 14, e086505. doi: 10.1136/bmjopen-2024-086505, PMID: 39806697 PMC11664386
  47. KakhandkiL. TakpereA. Y. BagaliS. WavareS. KarigoudarR. ShahapurP. R. (2020). Antibiogram of gram negative bacteria isolated from the skin and soft tissue infections a guide for empirical therapy to the clinicians. J. Pure Appl. Microbiol. 14, 1353–1358. doi: 10.22207/jpam.14.2.32
  48. Kaleem UllahM. MalamardiS. SiddaiahJ. B. AT. PrashantA. VishwanathP. . (2022). Trends in the bacterial prevalence and antibiotic resistance patterns in the acute exacerbation of chronic obstructive pulmonary disease in hospitalized patients in south India. Antibiotics 11, 1577. doi: 10.3390/antibiotics11111577, PMID: 36358232 PMC9686600
  49. KatipW. RayanakornA. OberdorferP. TaruangsriP. NampuanT. (2023). Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study. J. Infection Public Health 16, 1249–1255. doi: 10.1016/j.jiph.2023.05.024, PMID: 37295057
  50. KhalediA. SchniederjansM. PohlS. RainerR. BodenhoferU. XiaB. . (2016). Transcriptome profiling of antimicrobial resistance in pseudomonas aeruginosa. Antimicrobial Agents Chemotherapy 60, 4722–4733. doi: 10.1128/aac.00075-16, PMID: 27216077 PMC4958182
  51. KnoblochM. J. MckinleyL. KeatingJ. SafdarN. (2021). Integrating antibiotic stewardship and infection prevention and control programs using a team science approach. Am. J. Infection Control 49, 1072–1074. doi: 10.1016/j.ajic.2021.01.020, PMID: 33524453 PMC8060952
  52. KöhlerT. EppS. F. CurtyL. K. PechèreJ.-C. (1999). Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriology 181, 6300–6305. doi: 10.1128/jb.181.20.6300-6305.1999, PMID: 10515918 PMC103763
  53. KonvinseK. C. TrubianoJ. A. PavlosR. JamesI. ShafferC. M. BejanC. A. . (2019). HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. J. Allergy Clin. Immunol. 144, 183–192. doi: 10.1016/j.jaci.2019.01.045, PMID: 30776417 PMC6612297
  54. KulkarniN. RoutrayA. TaurS. (2023). A multicenter evaluation of overall susceptibility and antimicrobial resistance among Streptococcus pneumoniae isolates. Cureus 15, e41984. doi: 10.7759/cureus.41984, PMID: 37593286 PMC10427887
  55. KumarA. ChaudhryD. GoelN. TanwarS. (2021). Epidemiology of intensive care unit-acquired infections in a tertiary care hospital of north India. Indian J. Crit. Care Med. 25, 1427–1433. doi: 10.5005/jp-journals-10071-24058, PMID: 35027805 PMC8693113
  56. LancasterC. S. BruunG. H. PeerC. J. MikkelsenT. S. CorydonT. J. GibsonA. A. . (2012). OATP1B1 polymorphism as a determinant of erythromycin disposition. Clin. Pharmacol. Ther. 92, 642–650. doi: 10.1038/clpt.2012.106, PMID: 22990751 PMC3478421
  57. LaxminarayanR. ChaudhuryR. R. (2016). Antibiotic resistance in India: drivers and opportunities for action. PloS Med. 13, e1001974. doi: 10.1371/journal.pmed.1001974, PMID: 26934098 PMC4775002
  58. LemmenS. W. LewalterK. (2018). Antibiotic stewardship and horizontal infection control are more effective than screening, isolation and eradication. Infection 46, 581–590. doi: 10.1007/s15010-018-1137-1, PMID: 29796739 PMC6182449
  59. LiX. FengD. ZhouJ. WuW. ZhengW. GanW. . (2024). Metabolomics method in understanding and sensitizing carbapenem-resistant acinetobacter baumannii to meropenem. ACS Infect. Dis. 10, 184–195. doi: 10.1021/acsinfecdis.3c00480, PMID: 37991817 PMC10788854
  60. LibbrechtM. W. NobleW. S. (2015). Machine learning applications in genetics and genomics. Nat. Rev. Genet. 16, 321–332. doi: 10.1038/nrg3920, PMID: 25948244 PMC5204302
  61. LohiyaA. Suliankatchi AbdulkaderR. RathR. S. JacobO. ChinnakaliP. GoelA. D. . (2020). Prevalence and patterns of drug resistant pulmonary tuberculosis in India—A systematic review and meta-analysis. J. Global Antimicrobial Resistance 22, 308–316. doi: 10.1016/j.jgar.2020.03.008, PMID: 32247079
  62. LucenaM. I. MolokhiaM. ShenY. UrbanT. J. AithalG. P. AndradeR. J. . (2011). Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 141, 338–347. doi: 10.1053/j.gastro.2011.04.001, PMID: 21570397 PMC3129430
  63. MV. RP. MB. (2017). Prevalence of microorganisms causing catheter associated urinary tract infections (CAUTI) among catheterised patients admitted in a tertiary care hospital. Int. J. Res. Med. Sci. 5, 2367–2372. doi: 10.18203/2320-6012.ijrms20172084
  64. MahindrooJ. ThanhD. P. KaurH. NguyenT. H. T. CareyM. E. VermaR. . (2024). The genomic diversity and antimicrobial resistance of Non-typhoidal Salmonella in humans and food animals in Northern India. One Health 19, 100892. doi: 10.1016/j.onehlt.2024.100892, PMID: 39345727 PMC11439553
  65. MargalitA. CarolanJ. C. WalshF. (2022). Global protein responses of multidrug resistance plasmid-containing Escherichia coli to ampicillin, cefotaxime, imipenem and ciprofloxacin. J. Global Antimicrobial Resistance 28, 90–96. doi: 10.1016/j.jgar.2021.12.006, PMID: 34922055
  66. MassartN. MansourA. RossJ. T. PiauC. VerhoyeJ.-P. TattevinP. . (2022). Mortality due to hospital-acquired infection after cardiac surgery. J. Thorac. Cardiovasc. Surg. 163, 2131–2140.e3. doi: 10.1016/j.jtcvs.2020.08.094, PMID: 32981703
  67. Mat GhaniN. Kar-WaiH. MeiL. Y. J. YinL. Y. Hoi-SenY. KengT. K. . (2025). Whole genome analysis revealed the role of blaOXA-23 and blaOXA-66 genes in carbapenem resistance of Acinetobacter baumannii strains. Pathog. Global Health 119, 10–21. doi: 10.1080/20477724.2024.2442194, PMID: 39699991 PMC11905307
  68. MatherA. E. ReidS. W. J. MaskellD. J. ParkhillJ. FookesM. C. HarrisS. R. . (2013). Distinguishable epidemics within different hosts of the multidrug resistant zoonotic pathogen salmonella typhimurium DT. Science 341, 1514–1517. doi: 10.1126/science.1240578, PMID: 24030491 PMC4012302
  69. MathewP. RanjalkarJ. ChandyS. J. (2020). Challenges in implementing antimicrobial stewardship programmes at secondary level hospitals in India: an exploratory study. Front. Public Health 8. doi: 10.3389/fpubh.2020.493904, PMID: 33072690 PMC7531198
  70. McGettiganP. Alonso OlmoC. PlueschkeK. CastillonM. Nogueras ZondagD. BahriP. . (2019). Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments. Drug Saf. 42, 1343–1351. doi: 10.1007/s40264-019-00848-9, PMID: 31302896 PMC6834729
  71. MehrotraT. KonarD. PragasamA. K. KumarS. JanaP. BabeleP. . (2023). Antimicrobial resistance heterogeneity among multidrug-resistant Gram-negative pathogens: Phenotypic, genotypic, and proteomic analysis. Proc. Natl. Acad. Sci. 120, e2305465120. doi: 10.1073/pnas.2305465120, PMID: 37549252 PMC10434301
  72. MerkerM. TueffersL. VallierM. GrothE. E. SonnenkalbL. UnterwegerD. . (2020). Evolutionary approaches to combat antibiotic resistance: opportunities and challenges for precision medicine. Front. Immunol. 11. doi: 10.3389/fimmu.2020.01938, PMID: 32983122 PMC7481325
  73. ModgilV. SahayS. TanejaN. QayyumiB. SinghR. MukherjeeA. . (2025). Mapping the AMR infection landscape in bihar: implications for strengthening policy and clinical practice. Antibiotics 14, 684. doi: 10.3390/antibiotics14070684, PMID: 40723987 PMC12291626
  74. ModiC. SinghS. PandyaY. (2021). Prevalence of carbapenem resistant Enterobacteriaceae in a tertiary care hospital of Gujarat, India. Blood 273, 19. doi: 10.7860/JCDR/2021/47332.14627
  75. MohapatraS. PanigrahyR. TakV. J. VS. K. CS. ChaudhuriS. . (2022). Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India. Access Microbiol. 4, 000321. doi: 10.1099/acmi.0.000321, PMID: 35355869 PMC8941965
  76. MøllerT. S. B. LiuG. BoysenA. ThomsenL. E. LüthjeF. L. MortensenS. . (2017). Treatment with cefotaxime affects expression of conjugation associated proteins and conjugation transfer frequency of an IncI1 plasmid in Escherichia coli. Front. Microbiol. 8. doi: 10.3389/fmicb.2017.02365, PMID: 29238335 PMC5712592
  77. MorrisS. K. BassaniD. G. AwasthiS. KumarR. ShetA. SuraweeraW. . (2011). Diarrhea, pneumonia, and infectious disease mortality in children aged 5 to 14 years in India. PloS One 6, e20119. doi: 10.1371/journal.pone.0020119, PMID: 21629660 PMC3101242
  78. MukherjeeK. (2024). Antimicrobial Resistance and its Impact on Public Health. (Bhopal, India: Med Research)
  79. MurrayC. J. L. IkutaK. S. ShararaF. SwetschinskiL. AguilarG. R. GrayA. . (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655. doi: 10.1016/S0140-6736(21)02724-0, PMID: 35065702 PMC8841637
  80. NaidooA. NaidooK. McilleronH. EssackS. PadayatchiN. (2017). A review of moxifloxacin for the treatment of drug-susceptible tuberculosis. J. Clin. Pharmacol. 57, 1369–1386. doi: 10.1002/jcph.968, PMID: 28741299 PMC5663285
  81. NaidooA. RamsuranV. ChirehwaM. DentiP. McilleronH. NaidooK. . (2018). Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis. Pharmacogenomics 19, 17–29. doi: 10.2217/pgs-2017-0144, PMID: 29210323 PMC5753622
  82. NairM. EngelN. ZeegersM. P. BurzaS. (2023). Perceptions of effective policy interventions and strategies to address antibiotic misuse within primary healthcare in India: A qualitative study. J. Infection Prev. 24, 113–118. doi: 10.1177/17571774231158778, PMID: 37065277 PMC10090571
  83. NairM. ZeegersM. P. VargheseG. M. BurzaS. (2021). India’s National Action Plan on Antimicrobial Resistance: a critical perspective. J. Global Antimicrobial Resistance 27, 236–238. doi: 10.1016/j.jgar.2021.10.007, PMID: 34695609
  84. NaithaniN. SinhaS. MisraP. VasudevanB. SahuR. (2021). Precision medicine: Concept and tools. Med. J. Armed Forces India 77, 249–257. doi: 10.1016/j.mjafi.2021.06.021, PMID: 34305276 PMC8282508
  85. NandhiniP. KumarP. MickymarayS. AlothaimA. S. SomasundaramJ. RajanM. (2022). Recent developments in methicillin-resistant staphylococcus aureus (MRSA) treatment: A review. Antibiotics 11, 606. doi: 10.3390/antibiotics11050606, PMID: 35625250 PMC9137690
  86. NathwaniD. RamanG. SulhamK. GavaghanM. MenonV. (2014). Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrobial Resistance Infection Control 3, 32. doi: 10.1186/2047-2994-3-32, PMID: 25371812 PMC4219028
  87. OkekeI. N. De KrakerM. E. A. Van BoeckelT. P. KumarC. K. SchmittH. GalesA. C. . (2024). The scope of the antimicrobial resistance challenge. Lancet 403, 2426–2438. doi: 10.1016/S0140-6736(24)00876-6, PMID: 38797176
  88. PageS. W. GautierP. (2012). Use of antimicrobial agents in livestock. Rev. Sci. Tech 31, 145–188. doi: 10.20506/rst.31.1.2106, PMID: 22849274
  89. PatelC. ShahM. B. SinghS. ModiC. ShahP. (2021). Biofilm production and antimicrobial resistance in catheter associated urinary tract infection (CAUTI) pathogens isolated from ICU patients. Eur. J. Mol. Clin. Med. (EJMCM) 8, 2021. Available online at: https://www.researchgate.net/publication/365038922 (Accessed December 11, 2024).
  90. PengB. SuY.-B. LiH. HanY. GuoC. TianY.-M. . (2015). Exogenous Alanine and/or Glucose plus Kanamycin Kills Antibiotic-Resistant Bacteria. Cell Metab. 21, 249–262. doi: 10.1016/j.cmet.2015.01.008, PMID: 25651179
  91. PereiraN. R. Castro-SanchezE. NathwaniD. (2017). How can multi-professional education support better stewardship? Infect. Dis. Rep. 9, 6917. doi: 10.4081/idr.2017.6917, PMID: 28458801 PMC5391539
  92. PontoJ. A. (2010). ASHP statement on the pharmacist’s role in antimicrobial stewardship and infection prevention and control. Am. J. Health-System Pharm. 67, 575–577. doi: 10.2146/sp100001, PMID: 20237387
  93. PrabhuK. BhatP. N. BoloorR. ShettyA. K. NayakS. G. SundarsinghV. (2024). Clinico-microbiological profile of urosepsis patients in a tertiary care hospital in India: A 1-year study. J. Lab. Physicians 16, 387–92. doi: 10.25259/JLP_25_2024
  94. PrezantT. R. AgapianJ. V. BohlmanM. C. BuX. ÖztasS. QiuW.-Q. . (1993). Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafness. Nat. Genet. 4, 289–294. doi: 10.1038/ng0793-289, PMID: 7689389
  95. PulingamT. ParumasivamT. GazzaliA. M. SulaimanA. M. CheeJ. Y. LakshmananM. . (2022). Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur. J. Pharm. Sci. 170, 106103. doi: 10.1016/j.ejps.2021.106103, PMID: 34936936
  96. RamakrishnaM. S. JeyamaniL. AbimannanG. C. VajraveluL. K. (2021). Microbial profile and antibiogram pattern analysis of skin and soft tissue infections at a tertiary care center in South India. J. Pure Appl. Microbiol. 15, 915–925. doi: 10.22207/jpam.15.2.50
  97. RamsamyY. HardcastleT. C. MuckartD. J. J. (2017). Surviving sepsis in the intensive care unit: the challenge of antimicrobial resistance and the trauma patient. World J. Surg. 41, 1165–1169. doi: 10.1007/s00268-016-3531-0, PMID: 27146052
  98. RamzanM. AhmedA. SiddiquiA. J. KhanM. N. NisaZ. U. RazaA. . (2025). Understanding the pattern of resistance in multi-drug resistant clinical isolates of Acinetobacter baumannii based on metabolomics approach. Microbial Pathogenesis 200, 107307. doi: 10.1016/j.micpath.2025.107307, PMID: 39826862
  99. RanaS. KaurK. N. NaradP. WaliaK. SaeedS. ChandraA. . (2024). Knowledge, attitudes and practices of antimicrobial resistance awareness among healthcare workers in India: a systematic review. Front. Public Health 12. doi: 10.3389/fpubh.2024.1433430, PMID: 39104891 PMC11298436
  100. RavishankarU. PS. ThayanidhiP. (2021). Antimicrobial resistance among uropathogens: surveillance report from south India. Cureus 13, e12913. doi: 10.7759/cureus.12913, PMID: 33520560 PMC7837632
  101. RobertsJ. A. NorrisR. PatersonD. L. MartinJ. H. (2012). Therapeutic drug monitoring of antimicrobials. Br. J. Clin. Pharmacol. 73, 27–36. doi: 10.1111/j.1365-2125.2011.04080.x, PMID: 21831196 PMC3248253
  102. RonaldA. (2002). The etiology of urinary tract infection: traditional and emerging pathogens. Am. J. Med. 113, 14–19. doi: 10.1016/S0002-9343(02)01055-0, PMID: 12113867
  103. RoopashreeS. PrathabA. SandeepT. (2021). Bacteriological profile and antibiotic susceptibility patterns of wound infections in a tertiary care hospital in South India. Indian J. Microbiol. Res. 8, 76–85. doi: 10.18231/j.ijmr.2021.016
  104. SaikeerthanaD. PrabhaP. VijayashreeV. KrishnaG. N. (2021). Overview of Pathogens causing Nosocomial Infections in Various Wards of a Tertiary Health Care Hospital and their Antimicrobial Susceptibility Pattern-A Prospective Surveillance Study. J. Pure Appl. Microbiol. 15, 1940–6. doi: 10.22207/JPAM.15.4.15
  105. SanchezG. V. (2016). Core elements of outpatient antibiotic stewardship. MMWR. Recommendations Rep. 65, 1–12. doi: 10.15585/mmwr.rr6506a1, PMID: 27832047
  106. SandeepL. RajeshR. KrunalD. AshwiniP. YashpalC. AlapG. . (2020). Tackling AMR crisis in India: Changing paradigm. Asian J. Med. Sci. 11, 129–137. doi: 10.71152/ajms.v11i6.3940
  107. SangaleA. VivekB. KelkarR. BiswasS. (2021). Microbiology of ventilator-associated pneumonia in a tertiary care cancer hospital. Indian J. Crit. Care Med. 25, 421–428. doi: 10.5005/jp-journals-10071-23790, PMID: 34045810 PMC8138642
  108. ShahS. RampalR. ThakkarP. PoojaryS. LadiS. (2022). The prevalence and antimicrobial susceptibility pattern of gram-positive pathogens: three-year study at a tertiary care hospital in Mumbai, India. J. Lab. Physicians 14, 109–114. doi: 10.1055/s-0041-1731136, PMID: 35982886 PMC9381322
  109. SharmaS. K. BhadraS. SarwatT. KakruD. K. (2023b). Antibiotic Resistance Rate among Bacterial Pathogens Isolated from Bronchoalveolar Lavage Fluid at a Tertiary Care Center in Western Uttar Pradesh, India. J. Med. Microbiol. Infect. Dis. 11, 110–116. doi: 10.61186/JoMMID.11.2.110
  110. SharmaA. ThakurN. ThakurA. ChauhanA. BabrahH. (2023a). The challenge of antimicrobial resistance in the Indian healthcare system. Cureus 15, e42231. doi: 10.7759/cureus.42231, PMID: 37605711 PMC10440008
  111. ShetA. SundaresanS. ForsbergB. C. (2015). Pharmacy-based dispensing of antimicrobial agents without prescription in India: appropriateness and cost burden in the private sector. Antimicrobial Resistance Infection Control 4, 55. doi: 10.1186/s13756-015-0098-8, PMID: 26693005 PMC4676185
  112. ShrivastavaA. K. KumarS. MohakudN. K. SuarM. SahuP. S. (2017). Multiple etiologies of infectious diarrhea and concurrent infections in a pediatric outpatient-based screening study in Odisha, India. Gut Pathog. 9, 16. doi: 10.1186/s13099-017-0166-0, PMID: 28400860 PMC5387278
  113. SinghS. SharmaA. NagV. L. (2020). Bacterial pathogens from lower respiratory tract infections: A study from Western Rajasthan. J. Family Med. Primary Care 9, 1407–1412. doi: 10.4103/jfmpc.jfmpc_994_19, PMID: 32509624 PMC7266181
  114. SinghalT. RodriguesC. SomanR. WattalC. SwaminathanS. NambiS. . (2022). Treatment of MRSA infections in India: Clinical insights from a Delphi analysis. Indian J. Med. Microbiol. 40, 35–45. doi: 10.1016/j.ijmmb.2021.11.005, PMID: 34785281
  115. SmitaM. S. WavareS. S. GajulS. SajjanA. G. (2019). Bacterial profile of urinary tract infections and antibiotic resistance pattern in a tertiary care hospital. Online J. Health Allied Scs 18, 6. Available online at: https://www.ojhas.org/issue72/2019-4-6.html.
  116. SrivastavaR. AgarwalJ. SrivastavaS. MishraB. (2014). Role of special pathogenicity versus prevalence theory in pathogenesis of acute cystitis caused by Escherichia coli. J. Med. Microbiol. 63, 1038–1043. doi: 10.1099/jmm.0.073270-0, PMID: 24899598
  117. StephensC. López-NevotM.-Á. Ruiz-CabelloF. UlzurrunE. SorianoG. Romero-GómezM. . (2013). HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity. PloS One 8, e68111. doi: 10.1371/journal.pone.0068111, PMID: 23874514 PMC3706603
  118. StoccoG. LucafòM. DecortiG. (2020). Pharmacogenomics of antibiotics. Int. J. Mol. Sci. 21, 5975. doi: 10.3390/ijms21175975, PMID: 32825180 PMC7504675
  119. SundaramurthyG. EghbalniaH. R. (2015). A probabilistic approach for automated discovery of perturbed genes using expression data from microarray or RNA-Seq. Comput. Biol. Med. 67, 29–40. doi: 10.1016/j.compbiomed.2015.07.029, PMID: 26492320
  120. TangK. W. K. MillarB. C. MooreJ. E. (2023). Antimicrobial resistance (AMR). Br. J. Biomed. Sci. 80. doi: 10.3389/bjbs.2023.11387, PMID: 37448857 PMC10336207
  121. TognettiL. MartinelliC. BertiS. HercogovaJ. LottiT. LeonciniF. . (2012). Bacterial skin and soft tissue infections: review of the epidemiology, microbiology, aetiopathogenesis and treatment: A collaboration between dermatologists and infectivologists. J. Eur. Acad. Dermatol. Venereology 26, 931–941. doi: 10.1111/j.1468-3083.2011.04416.x, PMID: 22214317
  122. UmeshaL. ShivaprasadS. M. RajivE. N. KumarM. M. S. LeelavathyV. SreedharaC. G. . (2018). Acute pyelonephritis: A single-center experience. Indian J. Nephrol. 28, 454–461. doi: 10.4103/ijn.IJN_219_16, PMID: 30647500 PMC6309380
  123. UrbanT. J. NicolettiP. ChalasaniN. SerranoJ. StolzA. DalyA. K. . (2017). Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor. J. Hepatol. 67, 137–144. doi: 10.1016/j.jhep.2017.03.010, PMID: 28323125 PMC5634615
  124. VaithiyamV. S. RastogiN. RanjanP. MahishiN. KapilA. DwivediS. N. . (2020). Antimicrobial resistance patterns in clinically significant isolates from medical wards of a tertiary care hospital in north India. J. Lab. Physicians 12, 196–202. doi: 10.1055/s-0040-1721161, PMID: 33268937 PMC7684999
  125. WaliaK. OhriV. C. MadhumathiJ. RamasubramanianV. (2019). Policy document on antimicrobial stewardship practices in India. Indian J. Med. Res. 149, 180–184. doi: 10.4103/ijmr.IJMR_147_18, PMID: 31219081 PMC6563731
  126. WangD. CurtisA. PappA. C. KoletarS. L. ParaM. F. (2012). Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients. BMC Med. Genomics 5, 32. doi: 10.1186/1755-8794-5-32, PMID: 22824134 PMC3418550
  127. WangZ. LiM.-Y. PengB. ChengZ.-X. LiH. PengX.-X. (2016). GC–MS-based metabolome and metabolite regulation in serum-resistant Streptococcus agalactiae. J. Proteome Res. 15, 2246–2253. doi: 10.1021/acs.jproteome.6b00215, PMID: 27251450
  128. WatkinsR. R. (2022). Antibiotic stewardship in the era of precision medicine. JAC-Antimicrobial Resistance 4, dlac066. doi: 10.1093/jacamr/dlac066, PMID: 35733911 PMC9209748
  129. WattengelB. A. SellickJ. A. MergenhagenK. A. (2020). Outpatient antimicrobial stewardship: Optimizing patient care via pharmacist led microbiology review. Am. J. Infection Control 48, 189–193. doi: 10.1016/j.ajic.2019.07.018, PMID: 31492553
  130. WawruchM. BozekovaL. KrcmeryS. KriskaM. (2002). Risks of antibiotic treatment. Bratislavske lekarske listy 103, 270–275., PMID: 12519001
  131. WeinerM. BurmanW. LuoC.-C. PeloquinC. A. EngleM. GoldbergS. . (2007). Effects of rifampin and multidrug resistance gene polymorphism on concentrations of moxifloxacin. Antimicrobial Agents Chemotherapy 51, 2861–2866. doi: 10.1128/AAC.01621-06, PMID: 17517835 PMC1932492
  132. WeinerM. GelfondJ. Johnson-PaisT. L. EngleM. PeloquinC. A. JohnsonJ. L. . (2018). Elevated plasma moxifloxacin concentrations and SLCO1B1 g.– 11187G> A polymorphism in adults with pulmonary tuberculosis. Antimicrobial Agents Chemotherapy 62, 10.1128/aac. doi: 10.1128/AAC.01802-17, PMID: 29463526 PMC5923103
  133. World Health, O (2014). “ Antimicrobial resistance: global report on surveillance,” (Geneva: World Health Organization). Available online at: https://www.who.int/publications/i/item/9789241564748.
  134. World Health, O (2021). Ending the neglect to attain the sustainable development goals: a global strategy on water, sanitation and hygiene to combat neglected tropical diseases 2021–2030. Available online at: https://coilink.org/20.500.12592/7703wm (Accessed December 24, 2024).
  135. World Health, O (2024a). “ WHO bacterial priority pathogens list 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance,” (Geneva: World Health Organization). Available online at: https://www.who.int/publications/i/item/9789240093461.
  136. World Health, O (2024b). The Work of the World Health Organization in the African Region (Brazzaville: World Health Organization). Available online at: https://www.afro.who.int/sites/default/files/2024-08/WHO_AnnualReport_0.pdf (Accessed December 24, 2024).
  137. WuJ. YangF. YangH. ZhangG. MuK. FengJ. . (2021). Prevalence of antibiotic self-medication behavior and related factors among children aged 0 to 5 years. Expert Rev. Anti-infective Ther. 19, 1157–1164. doi: 10.1080/14787210.2021.1882303, PMID: 33507127
  138. YangY. ChenS. YangF. ZhangL. AlterovitzG. ZhuH. . (2017). HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions. Pharmacogenomics J. 17, 501–505. doi: 10.1038/tpj.2016.61, PMID: 27527109
  139. YeeS. W. NguyenA. N. BrownC. SavicR. M. ZhangY. CastroR. A. . (2013). Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8). J. Pharm. Sci. 102, 3451–3457. doi: 10.1002/jps.23581, PMID: 23649425 PMC4151246
  140. ZhaoX.-L. ChenZ.-G. YangT.-C. JiangM. WangJ. ChengZ.-X. . (2021). Glutamine promotes antibiotic uptake to kill multidrug-resistant uropathogenic bacteria. Sci. Trans. Med. 13, eabj0716. doi: 10.1126/scitranslmed.abj0716, PMID: 34936385
  141. ZhouY. YongY. ZhuC. YangH. FangB. (2022). Exogenous D-ribose promotes gentamicin treatment of several drug-resistant Salmonella. Front. Microbiol. 13. doi: 10.3389/fmicb.2022.1053330, PMID: 36419438 PMC9676500